Theophylline disposition in obesity
- PMID: 630791
- DOI: 10.1002/cpt1978234438
Theophylline disposition in obesity
Abstract
Theophylline disposition was examined in 14 obese subjects and 57 normal subjects. A single oral dose of aminophylline solution was given and serum and saliva samples were collected over several hours and assayed by high-pressure liquid chromatography. The apparent volume of distribution (Vd) and body clearance (ClB) were analyzed for total body weight (TBW) and ideal body weight (IBW). The Vd averaged 0.482 (SD = 0.084) L/kg TBW in normals vs 0.382 (0.069) L/kg TBW and 0.77 (0.189) L/kg IBW in obese subjects. The ClB averaged 63.0 (28.5) ml/hr/kg IBW in normals compared to 32.8 (11.1) ml/hr/kg TBW and 64.1 (20.8) ml/hr/kg IBW in obese subjects. Similar Vd values between the two groups when TBW is used indicates that loading dose is best calculated based on TBW. Similar ClB based on IBW in normal and obese subjects indicates that IBW should be used to calculate maintenance doses for theophylline. Mean half-lives were longer in obese subjects than in normals, 8.6 (2.0) and 6.0 (2.1) hr, respectively, suggesting that obese patients may need less frequent dosing.
Similar articles
-
The effect of obesity on apparent volume of distribution of theophylline.Pediatr Pharmacol (New York). 1982;2(1):75-83. Pediatr Pharmacol (New York). 1982. PMID: 7110759
-
Theophylline clearance: effect of marked obesity.Clin Pharmacol Ther. 1980 Nov;28(5):619-23. doi: 10.1038/clpt.1980.212. Clin Pharmacol Ther. 1980. PMID: 7438680
-
Influence of body fat on the volume of distribution of theophylline.Ther Drug Monit. 1985;7(2):197-201. doi: 10.1097/00007691-198506000-00010. Ther Drug Monit. 1985. PMID: 4024213
-
Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.Clin Pharmacokinet. 2000 May;38(5):415-26. doi: 10.2165/00003088-200038050-00003. Clin Pharmacokinet. 2000. PMID: 10843460 Review.
-
Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy.J Clin Pharmacol. 2022 Nov;62(11):1350-1363. doi: 10.1002/jcph.2093. Epub 2022 Jul 7. J Clin Pharmacol. 2022. PMID: 35661375 Review.
Cited by
-
Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.Clin Pharmacokinet. 1995 Apr;28(4):287-314. doi: 10.2165/00003088-199528040-00003. Clin Pharmacokinet. 1995. PMID: 7648758 Review.
-
A hand-held calculator program for individualized dosage adjustment of intravenous theophylline in acute asthma.Eur J Clin Pharmacol. 1980 May;17(5):393-9. doi: 10.1007/BF00558454. Eur J Clin Pharmacol. 1980. PMID: 7418718
-
Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.Cancer Chemother Pharmacol. 1989;25(2):139-42. doi: 10.1007/BF00692355. Cancer Chemother Pharmacol. 1989. PMID: 2557169
-
Personality and theophylline pharmacokinetics.Eur J Clin Pharmacol. 1985;28(4):429-31. doi: 10.1007/BF00544362. Eur J Clin Pharmacol. 1985. PMID: 4029249
-
Relationship of bioelectrical impedance to pharmacokinetic parameters of theophylline in healthy males.Clin Pharmacokinet. 1989 Sep;17(3):200-7. doi: 10.2165/00003088-198917030-00005. Clin Pharmacokinet. 1989. PMID: 2805551